Valuation : Guerbet

Market Cap 94.61M 110M 89.27M 81.32M 152M 10.52B 153M 1.06B 409M 5.34B 413M 404M 16.95B P/E 2026 *
-4.2x
P/E 2027 * 8.16x
Enterprise Value 470M 547M 444M 404M 756M 52.28B 762M 5.28B 2.03B 26.51B 2.05B 2.01B 84.22B EV / Sales 2026 *
0.62x
EV / Sales 2027 * 0.58x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.11%
1 day+4.97%
1 week-0.85%
Current month-3.58%
1 month-10.14%
3 months-27.46%
6 months-41.67%
Current year-50.35%
1 week 7
Extreme 7
7.05
1 month 7
Extreme 7
7.84
Current year 7
Extreme 7
14.92
1 year 7
Extreme 7
19.64
3 years 7
Extreme 7
39.4
5 years 7
Extreme 7
43.65
10 years 7
Extreme 7
89.68
Manager TitleAgeSince
Chief Executive Officer - 01/02/2026
Chief Executive Officer - 21/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 28/05/2015
Director/Board Member 50 18/05/2017
Director/Board Member 52 21/11/2023
Change 5-day change 1-year change 3-year change Capi.($)
+5.82%-0.85% - - 110M
-1.10%-2.59%-32.79%-3.53% 12.47B
+0.10%-2.67%+14.88%+12.26% 4.22B
-2.44%+2.68%-44.78%-53.01% 1.26B
+0.38%-4.62%-42.76%-41.78% 1.1B
+1.28%-5.45%+14.47%+73.42% 1.05B
-2.49%-4.91%-39.59% - 976M
-3.32%-8.14% - - 967M
-2.08%-2.12%+34.20%+107.42% 510M
+1.30%+9.21%+79.61% - 326M
Average -0.39%-1.83%-2.09%+15.79% 2.54B
Weighted average by Cap. -0.91%-3.96%-19.60%+1.29%

Financials

2026 *2027 *
Net sales 764M 888M 721M 657M 1.23B 84.92B 1.24B 8.58B 3.3B 43.07B 3.34B 3.26B 137B 798M 928M 753M 686M 1.28B 88.74B 1.29B 8.97B 3.45B 45.01B 3.49B 3.41B 143B
Net income -35.8M -41.63M -33.78M -30.77M -57.52M -3.98B -58.05M -402M -155M -2.02B -156M -153M -6.41B 8.3M 9.65M 7.83M 7.13M 13.34M 923M 13.46M 93.27M 35.9M 468M 36.24M 35.45M 1.49B
Net Debt 376M 437M 354M 323M 604M 41.76B 609M 4.22B 1.62B 21.18B 1.64B 1.6B 67.27B 370M 431M 349M 318M 595M 41.17B 600M 4.16B 1.6B 20.88B 1.62B 1.58B 66.33B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change
11/09/26 7.000 -0.57%
10/09/26 €7.040 +0.28%
09/09/26 €7.020 -0.43%
08/09/26 €7.050 +0.71%
07/09/26 €7.000 -0.85%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
7.500EUR
Average target price
8.433EUR
Spread / Average Target
+12.44%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!